• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology

    PR NEWSWIRE

    iNtRON, Executes Evaluation License and Option Agreement for SAL200

    PR NEWSWIRE

    iNtRON Signs Bacteriophage Development Project with U.S. Army DEVCOM

    PR NEWSWIRE

    iNtRON identifies Prophage &Jamphage in the Pancreatic cancer related Microbiome

    PR NEWSWIRE

    iNtRON Confirms Efficacy of CDL200 Against CDI Clinical Isolates

    PRNEWSWIRE

    iNtRON Completes GLP-TOX Studies of BAL200

    PRNEWSWIRE

    iNtRON Biotechnology, Inc., Launches New Website

    PRNEWSWIRE

    Intron Bio secures new drug substance for bacterial pneumonia

    KOREABIOMEDICALREVIEW

    Roivant joins forces with Korea’s iNtRON Bio to fight superbugs

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.